Ana Velosa

Disease Spotlight

When faced with a devastating diagnosis, a family has two choices – to give up or make it their mission to adapt and carry on.

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.